3BNC117-LS and 10-1074-LS Plus N-803 (bNAb+N-803)

NCT05245292 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

28

Enrollment

OTHER

Sponsor class

Conditions

Human Immunodeficiency Virus

Interventions

DRUG: 3BNC117-LS
DRUG: 10-1074-LS
DRUG: N803

Sponsor

Rockefeller University

Collaborators

[object Object]
[object Object]
[object Object]